Fingerprint
Dive into the research topics of 'A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice
Jae Hyeog Choi, Ki Hyang Kim, Kug Hwan Roh, Hana Jung, Anbok Lee, Ji Young Lee, Joo Yeon Song, Seung Jae Park, Ilhwan Kim, Won Sik Lee, Su Kil Seo, Il Whan Choi, Yang Xin Fu, Sung Su Yea, Sae Gwang Park
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations